Close

UPDATE: Raymond James Downgrades Viking Therapeutic (VKTX) to Outperform

Go back to UPDATE: Raymond James Downgrades Viking Therapeutic (VKTX) to Outperform
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 65.07 +0.14 (0.22%)
Previous Close $64.93    52 Week High $5.17 
Open $65.75    52 Week Low $0.94 
Day High $67.78    P/E N/A 
Day Low $64.43    EPS $0.00 
Volume 2,582,827